Nanobiotix S A 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 15.26, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Nanobiotix S A 's Accounts Receivable average collection period in the Dec 31 2025 quarter, has decreased to 24 days, from -119 days, in the 0 quarter.

If we take a look into Healthcare sector 298 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 2190.

What is Receivable Turnover Ratio?
What is Nanobiotix S A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBTX Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-28.25 %	-28.25 %	-28.25 %	-28.25 %	228.95 %
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	15.26	-	-	-	-
NBTX's Total Ranking	# 2190	# 0	#	#	#
Accounts Receivable average collection period days	24	-	-	-	-
Seq. Receivable Change	0 %	0 %	0 %	-28.25 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 88
Healthcare Sector	# 299
Overall Market	# 2190

Receivable Turnover Ratio Statistics
High	Average	Low
0.48	0.15	-0.11
(Dec 31 2025)		(Dec 31 2024)

NBTX Company Profile • Back to NBTX Efficiency Comparisons • Compare NBTX Receivables Turnover Ratio to its Competitors

Financial Statements
Nanobiotix S A 's Accounts Receivable	$ 2 Millions	Visit NBTX's Balance sheet
Nanobiotix S A 's Sales TTM	$ 37 Millions	Visit NBTX's Income Statement
Sources of NBTX's Revenues		Visit NBTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NBTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NBTX's Growth Rates	NBTX's Roa	NBTX's Inventory Turnover Ratio	NBTX's Dividend Comparisons
NBTX's Profitability Ratios	NBTX's Roi	NBTX's Asset Turnover Ratio	NBTX's Dividend Growth
NBTX's Valuation Ratios	NBTX's Roe	NBTX's Financial Strength Ratios	NBTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Kyntra Bio Inc	41.55	$ 6.440 Millions	$ 0.155 Millions
Cytomx Therapeutics Inc	40.82	$ 76.201 Millions	$ 1.867 Millions
Solana Company	40.38	$ 6.017 Millions	$ 0.149 Millions
Atara Biotherapeutics Inc	40.31	$ 121.355 Millions	$ 3.010 Millions
Nature s Sunshine Products inc	39.85	$ 479.724 Millions	$ 12.040 Millions
National Vision Holdings Inc	39.24	$ 1,987.488 Millions	$ 50.646 Millions
Lineage Cell Therapeutics Inc	39.16	$ 14.556 Millions	$ 0.372 Millions
Monte Rosa Therapeutics Inc	37.07	$ 123.672 Millions	$ 3.336 Millions
Meiragtx Holdings Plc	36.74	$ 81.391 Millions	$ 2.215 Millions
Protagonist Therapeutics inc	35.26	$ 46.016 Millions	$ 1.305 Millions
Stoke Therapeutics Inc	35.18	$ 184.420 Millions	$ 5.243 Millions
Agenus Inc	32.27	$ 114.196 Millions	$ 3.539 Millions
Metagenomi Therapeutics Inc	32.01	$ 25.210 Millions	$ 0.788 Millions
U S Physical Therapy Inc	30.83	$ 780.990 Millions	$ 25.331 Millions
Invo Fertility Inc	30.16	$ 6.841 Millions	$ 0.227 Millions
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Aesthetic Medical International Holdings Group Limited	28.50	$ 106.636 Millions	$ 3.742 Millions
Puretech Health Plc	28.24	$ 4.659 Millions	$ 0.165 Millions
Evotec Se	26.89	$ 882.978 Millions	$ 32.835 Millions
Electrocore Inc	26.63	$ 31.800 Millions	$ 1.194 Millions
Premier Air Charter Holdings Inc	26.15	$ 31.878 Millions	$ 1.219 Millions
Biontech Se	25.93	$ 3,214.288 Millions	$ 123.984 Millions
Polomar Health Services, Inc.	25.80	$ 0.648 Millions	$ 0.025 Millions
Cv Sciences Inc	25.56	$ 11.388 Millions	$ 0.446 Millions
Keros Therapeutics Inc	24.31	$ 257.786 Millions	$ 10.604 Millions
Innovage Holding Corp	23.84	$ 915.371 Millions	$ 38.393 Millions
Newgenivf Group Limited	23.64	$ 4.726 Millions	$ 0.200 Millions
Valneva Se	23.01	$ 195.618 Millions	$ 8.501 Millions
Legend Biotech Corporation	22.81	$ 1,028.900 Millions	$ 45.100 Millions
Longeveron Inc	22.20	$ 1.199 Millions	$ 0.054 Millions

Date modified: 2026-07-07T12:18:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.